NGHIÊN CỨU ĐẶC ĐIỂM LÂM SÀNG, MỨC ĐỘ LO ÂU, SỰ HÀI LÒNG VỀ KẾT QUẢ ĐIỀU TRỊ TẠI CHỖ VIÊM DA DO LỆ THUỘC CORTICOID (FCAD) BẰNG SENSIVE SERUM VÀ DUNG DỊCH MEDLO NĂM 2022-2024

Abstract

Background: “Facial corticosteroid-addictive dermatitis (FCAD)” appeared in 2006, referring to chronic inflammatory lesions on the facial skin caused by long-term use of corticosteroid-containing preparations. It has diverse clinical symptoms and is a relatively difficult disease to treat completely. Medlo and Sensive serum meet the treatment requirements, but have never been studied in combination to treat FCAD before. Objectives: Describe clinical characteristics and anxiety levels in patients with corticosteroid-dependent dermatitis (FCAD) coming for examination in 2022 - 2024. Evaluating the results of topical treatment with Sensive serum combined with Medlo and the level of satisfaction in patients with corticosteroid-dependent dermatitis (FCAD) in 2022 – 2024. Materials and methods: The patient was diagnosed with corticosteroid addictive dermatitis of the face at the FOB Cosmetic Skin Research Institute. Cross-sectional descriptive study. Results: The majority of patients are female (96,7%), aged >30% (78,3%), and mainly housewives (35%); FCAD patients had anxiety symptoms before treatment, accounting for 58,3%; Actually, Anxiety accounts for 21,7% and after treatment, the anxiety rate is 0% and only 5% have anxiety symptoms. The majority of patients had moderate severity (70%), severe severity 17%, and mild severity 13%. There is a difference in treatment results between the number of times Medlo is applied and Sensive serum is applied; There is a relationship between applying Medlo and applying Sensive serum with the level of treatment response (p < 0,001); After 12 weeks of treatment, patient satisfaction with symptom improvement reached 80,5±8,7; Treatment-related satisfaction 83,2 ± 7,1; Satisfaction with social life 87,9 ± 5,6; After 24 weeks, symptom satisfaction level was 91,9 ± 4,5; Treatment-related satisfaction 92,9 ± 3,9 and Satisfaction with social life 95,1 ± 3,8; The difference is statistically significant p < 0,001.  Conclusions: FCAD patients are mostly female, age group >30 years old, and housewives; Before treatment, 21,7% of FCAD patients had anxiety, and 0% of them had anxiety after treatment. There is a relationship between applying Medlo and Sensive serum with the level of treatment response p < 0,001; There is a difference in patient satisfaction after 12 weeks and 24 weeks of treatment